Aminoglycosides: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
|||
| Line 6: | Line 6: | ||
**Bacterial [[endocarditis]] | **Bacterial [[endocarditis]] | ||
*Used +/- [[beta-lactam]] | *Used +/- [[beta-lactam]] | ||
*Can precipitate crisis in patients with [[myasthenia gravis]] | *Nephro and oto toxicic. Risk of neuromuscular blockade. | ||
*Can precipitate crisis in patients with [[myasthenia gravis]] | |||
==See Also== | ==See Also== | ||
Revision as of 07:42, 18 March 2017
Background
- Used (alone or with beta-lactam) to treat serious infections due to gram-negative bacilli, e.g.:
- Ill patient with pyelonephritis
- Meningitis (due to pseudomonas, acinetobacter)
- Peritoneal dialysis-associated peritonitis
- Bacterial endocarditis
- Used +/- beta-lactam
- Nephro and oto toxicic. Risk of neuromuscular blockade.
- Can precipitate crisis in patients with myasthenia gravis
See Also
References
Goodman & Gilman's Pharmacology
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||